Trial Site Detail

 

Drug:
BKM120 + MEK162
Trial:
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

National Cancer Center

     
Singapore ,
Singapore

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
National Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.